Emergent BioSolutions | EBS - Market Capitalization

Stock Price
10.93
Daily Change
-0.06 -0.55%
Monthly
-4.96%
Yearly
41.76%
Q1 Forecast
10.65

Emergent BioSolutions reported $573.7M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Akebia Therapeutics USD 322M 180M Jun/2025
ALKERMES USD 5.65B 696M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amarin USD 341M 4M Sep/2025
ANI Pharmaceuticals USD 2.04B 630M Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Coherus Biosciences USD 278M 184M Jun/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Exact Sciences USD 10.36B 334M Sep/2025
Exelixis USD 12.27B 523M Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Heron Therapeutics USD 145M 6M Sep/2023
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Ironwood Pharmaceuticals USD 213M 97M Sep/2025
Lexicon Pharmaceuticals USD 267M 294M Sep/2023
Lonza CHF 39.68B 980.61M Jun/2025
Merck USD 300.37B 39.11B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Myriad Genetics USD 494M 316M Jun/2025
Nektar Therapeutics USD 113M 4M Sep/2023
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Pacira USD 1.16B 51M Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025
Vanda Pharmaceuticals USD 243M 136M Dec/2023
Xoma USD 162M 55M Sep/2023